Dow Jones (DJIA) Today: E I Du Pont De Nemours & Company (DD) Higher

The Dow component leading the way higher looks to be E I du Pont de Nemours & Company (NYSE:DD), which is sporting a 34-cent gain (+0.4%) bringing the stock to $78.48.

By Naomi Hossain , Mar 9, 2015 12:00 PM EDT

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link

The

Dow Jones Industrial Average

(

^DJI

) is trading up 114 points (+0.6%) at 17,970 as of Monday, Mar 9, 2015, 11:36 a.m. ET. During this time, 104.8 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 372.2 million. The NYSE advances/declines ratio sits at 1,691 issues advancing vs. 1,281 declining with 164 unchanged.

EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

The Dow component leading the way higher looks to be

E I du Pont de Nemours & Company

(NYSE:

), which is sporting a 34-cent gain (+0.4%) bringing the stock to $78.48. This single gain is lifting the Dow Jones Industrial Average by 2.57 points or roughly accounting for 2.3% of the Dow's overall gain. Volume for E I du Pont de Nemours & Company currently sits at 2.9 million shares traded vs. an average daily trading volume of 3.8 million shares.

E I du Pont de Nemours & Company has a market cap of $70.91 billion and is part of the basic materials sector and chemicals industry. Shares are up 5.7% year-to-date as of Friday's close. The stock's dividend yield sits at 2.4%.

E. I. du Pont de Nemours and Company operates as a science and technology based company worldwide. The company's Agriculture segment offers corn hybrid, soybean, canola, sunflower, sorghum, inoculants, seed products, wheat, rice, herbicides, fungicides, and insecticides.

TheStreet Ratings rates E I du Pont de Nemours & Company as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, increase in net income, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.